Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × sintilimab × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1

Conditions

Sarcoma 2 Osteosarcoma 1 Hemangiosarcoma 1 Adenocarcinoma of Lung 1

Interventions

sintilimab 1 enzalutamide 1 Pemetrexed 1 Midazolam 1 Letrozole 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Fulvestrant 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04861948 2022-10-04

IBI188 Combination Therapy in Solid Tumors

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Terminated

SarcomaThoracic

Adenocarcinoma of Lung, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡